Related Experiment Video
Updated: Jun 30, 2026
11:18
Isolation of Myofibroblasts from Mouse and Human Esophagus
Published on: January 18, 2015
Noneosinophilic asthma: a distinct clinical and pathologic phenotype
1Institute for Lung Health, Department of Respiratory Medicine, Glenfield Hospital, Leicester, UK.
The Journal of Allergy and Clinical Immunology
|May 3, 2007
Summary
Noneosinophilic asthma, lacking eosinophils in sputum, is a distinct phenotype. This asthma subtype shows unique lower airway pathology and a reduced response to corticosteroid therapy.
Area of Science:
- Pulmonology
- Immunology
- Pathology
Background:
- Induced sputum analysis reveals a significant subset of asthma patients lack eosinophilic airway inflammation.
- This non-eosinophilic asthma is observed across varying asthma severity and during exacerbations.
- The distinct pathological and clinical relevance of non-eosinophilic asthma remains to be fully elucidated.
Purpose of the Study:
- To review current evidence on non-eosinophilic asthma as a distinct phenotype.
- To explore the underlying pathology, immune pathways, and structural changes.
- To discuss the clinical implications regarding natural history and treatment response.
Main Methods:
- Review of recent scientific literature and evidence.
- Analysis of studies investigating airway inflammation markers.
- Examination of data on asthma phenotypes and treatment outcomes.
Main Results:
- Non-eosinophilic asthma presents as a stable phenotype with distinct lower airway pathology and structure.
- Inflammation in this phenotype may involve innate immune pathways, contributing to airway dysfunction.
- This asthma subtype demonstrates clinically significant differences in natural history and treatment response.
Conclusions:
- Non-eosinophilic asthma is a distinct phenotype with unique lower airway pathology.
- It is associated with specific immune responses and airway dysfunction.
- Crucially, it shows a diminished response to corticosteroid therapy, impacting treatment strategies.
More Related Videos
Related Concept Videos
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:26Asthma-II: Pathophysiology and Classification
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:30Asthma-IV: Diagnostic and Management
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:28Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
01:13Asthma III: Clinical Manifestations
Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.